Thank you for sharing!

Your article was successfully shared with the contacts you provided.

A provision in the Dodd-Frank financial reform law that hiked monetary awards for taking evidence of wrongdoing directly to the Securities and Exchange Commission and the Commodities Futures Trading Commission is starting to reverberate. The Wall Street Journal reports that an existing whistleblower law resulted in a settlement of $750 million between GlaxoSmithKline and the Justice Department last week, with the former Glaxo quality assurance manager who was involved in line to receive $96 million. Companies fear new laws will lead to increased costs and undermine their internal fraud detection efforts.

Treasury & Risk

Join Treasury & Risk

Don’t miss crucial treasury and finance news along with in-depth analysis and insights you need to make informed treasury decisions. Join Treasury & Risk now!

  • Free unlimited access to Treasury & Risk including case studies with corporate innovators, informative newsletters, educational webcasts, and resources from industry leaders.
  • Exclusive discounts on ALM and Treasury & Risk events.
  • Access to other award-winning ALM publications including PropertyCasualty360.com and Law.com.

Already have an account? Sign In Now
Join Treasury & Risk

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.